Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children
NCT ID: NCT03160742
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1 participants
OBSERVATIONAL
2018-04-25
2018-09-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting Pediatric Pulmonary Vein Stenosis Outcomes Using Data Acquired During a Cardiac Catheterization
NCT04696289
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
NCT05268094
Validation of a Novel Non-invasive Continuous Blood Pressure Monitor in Children Ages 2- 17 Years-old
NCT04817137
Estimation of Central Venous Pressure by Echocardiography in Intubated Children in Pediatric Intensive Care
NCT05195424
Evaluation of Electrocardiographic Guidance in Accurate Peripherally Inserted Central Catheter Placement in Children.
NCT02324504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Being able to reliably measure the CVP noninvasively would be of great benefit for sick children as it may allow diagnoses to be made quickly and help guide treatment.
The goal of this proposal is to determine the feasibility and accuracy of Mespere Life Science non-invasive central venous pressure monitoring system (Mespere VENUS 2000CVP system) in children with congenital heart disease (CHD).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-invasive monitoring
In addition to standard monitoring, the Mespere VENUS 200CVP system will be used to record central venous pressures.
Mespere VENUS 200CVP system
Non-invasive sensor placed on the neck
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mespere VENUS 200CVP system
Non-invasive sensor placed on the neck
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled to undergo a cardiac surgery with central venous pressure catheter monitoring at Boston Children's Hospital
Exclusion Criteria
* Have a known venous occlusion or any other reason the central venous pressure may be unreliable
* Allergy to medical grade adhesives or have any pre-existing skin irritation/eczema at the sensor site
* Emergently scheduled procedures
12 Months
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mespere Lifesciences Inc.
INDUSTRY
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kirsten Odegard
Cardiac Anesthesiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirsten Odegard, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-P00024295
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.